Royal Bank of Canada upgraded shares of Reckitt Benckiser Group (OTCMKTS:RBGLY – Get Rating) from a sector perform rating to an outperform rating in a research report sent to investors on Wednesday, The Fly reports.
Other equities research analysts also recently issued reports about the stock. Exane BNP Paribas raised shares of Reckitt Benckiser Group from an underperform rating to a neutral rating in a research note on Monday, March 14th. Jefferies Financial Group downgraded Reckitt Benckiser Group from a hold rating to an underperform rating in a report on Wednesday, March 23rd. Societe Generale cut shares of Reckitt Benckiser Group from a buy rating to a sell rating in a research report on Wednesday, March 16th. Sanford C. Bernstein cut shares of Reckitt Benckiser Group from a market perform rating to an underperform rating in a research note on Monday, March 14th. Finally, Zacks Investment Research upgraded Reckitt Benckiser Group from a sell rating to a hold rating in a research note on Thursday, March 24th. Three analysts have rated the stock with a sell rating, two have issued a hold rating and eight have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of Hold and an average target price of $6,364.00.
Shares of RBGLY stock opened at $15.64 on Wednesday. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.62 and a quick ratio of 0.44. Reckitt Benckiser Group has a 12-month low of $14.40 and a 12-month high of $19.17. The firm has a 50-day moving average price of $15.70 and a 200 day moving average price of $16.36.
About Reckitt Benckiser Group (Get Rating)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom, the United States, China, India, and internationally. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
- Get a free copy of the StockNews.com research report on Reckitt Benckiser Group (RBGLY)
- MarketBeat Podcast: Options Trading As Easy As Trading Stocks
- The TJX Companies: It’s Not All Doom And Gloom In Retail
- Simply Good Foods Stock is Simply Looking Good Down Here
- Shoe Carnival’s Q1 Results Are No Joke, Shares Fall 15%
- Analog Devices Is Ready To Scale New Highs Despite Tech Wreck
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.